top of page
  • Research Gate
  • YouTube
  • Instagram
  • Facebook
  • LinkedIn
  • X

About

Mission

Vision

To deliver oncology care that is rooted in compassionate humanism and guided by global scientific excellence. We strive to provide every patient with a tailored, precision treatment strategy that ensures high-quality outcomes while advocating for the affordability and accessibility of life-saving therapies in India.

To redefine the standard of cancer management across India by pioneering clinical research, leading advancements in precision medicine, and mentoring the next generation of specialists to ensure sustained clinical excellence and public health equity for all populations.

Dr. Satheesh C T
A Journey of Dedication

Dr. Satheesh C T’s journey is defined by an extraordinary dedication to service and academic rigor. His professional ethos is rooted in his upbringing in the rural village of Pandamatti, Karnataka, where he began his education in a Kannada-medium school while supporting his family’s agricultural work. This foundational experience instilled a profound empathy that characterizes his patient-centric practice today.

​

  • Pioneering Specialization: His medical focus began with an MD Paediatrics, training him in highly sensitive, family-centered care. This led him to achieve the highly competitive All India Rank-1 in the RGUHS Entrance Test for his super-specialization, DM Medical Oncology from KMIO Bangalore.

​

  • Strategic Growth: Recognizing the imperative for effective institutional management, he further completed an MBA in Hospital Administration, equipping him with the strategic expertise necessary to direct large-scale clinical research operations and optimize healthcare delivery systems.

Pioneering Research and Innovation

Dr. Satheesh is the Director of Clinical Trials at the HCG Group of Hospitals, instrumental in accelerating access to breakthrough cancer treatments in India. He has been integral to the clinical management of over 500 eligible cancer patients through participation in over 90 clinical trials (Phase I, II, and III)​

Principal Investigator in Global Landmark Studies: He has led pivotal international studies that redefine standards of care:​

​

  • HIMALAYA: Established a highly impactful immunotherapy regimen for unresectable Liver Cancer (uHCC).   

  • FLAURA-2: Contributed to the trial that established a combination therapy providing the longest overall survival reported in EGFR-Mutated Lung Cancers.   

  • DESTINY-Breast09: Investigating the use of the potent Antibody-Drug Conjugate (ADC) Trastuzumab Deruxtecan in the first-line setting for aggressive Breast Cancer. 

Advocacy for Affordability: He has served as a key investigator in numerous bioequivalence studies for biosimilars (including Trastuzumab and Rituximab), actively validating high-quality, cost-effective biological alternatives to improve drug accessibility for Indian patients.

National Influence, Global Authority

Dr. Satheesh C T’s professional journey is a powerful story of dedication that spans from his roots in rural Karnataka to global leadership in oncology. His impact is measured not just by his qualifications, but by his commitment to advancing medical standards and mentoring the next generation.

​​

  • National Oncology Leadership: Dr. Satheesh served as the President of the Association of Medical Oncologists of India (AMIO) from 2017 to 2020. In this critical role, he spearheaded efforts to professionalize oncology standards and promote scientific discourse across the nation.   

  • Academic Distinction: All India Rank-1: He achieved the highest recognition in his field by earning the All India Rank-1 in the entrance test for his super-specialization, DM Medical Oncology.   

  • Global Authority: His adherence to international clinical standards is recognized through his Fellowship of the Royal College of Physicians (FRCP) in Edinburgh and certification from the European Society for Medical Oncology (ESMO).   

  • Pioneering Awards: His research contributions have earned global recognition, including the prestigious Young Oncologist Developing Nation Award (ESMO-ECCO, 2009) and the IASLC International Mentorship Award (WCLC, 2016) for his work in lung cancer.   

  • Professor & Mentor: As a Professor and dedicated teaching faculty for DNB Medical Oncology students and oncology nursing staff since 2010, he ensures the continuity of high-quality care by training the next generation of specialists at HCG.

bottom of page